个人信息Personal Information
副教授
博士生导师
硕士生导师
性别:男
毕业院校:中国协和医科大学
学位:博士
所在单位:生物工程学院
学科:生物化工. 微生物学. 微生物与生化药学
办公地点:辽宁省大连市高新园区凌工路2号大连理工大学西部校区生物工程学院309室
联系方式:辽宁省大连市高新园区凌工路2号大连理工大学生物工程学院
电子邮箱:yshdong@dlut.edu.cn
Oroxin A from Oroxylum indicum prevents the progression from prediabetes to diabetes in streptozotocin and high-fat diet induced mice.
点击次数:
论文类型:期刊论文
发表时间:2018-01-01
发表刊物:Phytomedicine : international journal of phytotherapy and phytopharmacology
收录刊物:SCIE、PubMed、Scopus
卷号:38
页面范围:24-34
ISSN号:1618-095X
关键字:Mechanism,Oroxin A,PPARγ,Prediabetes,Type 2 diabetes
摘要:BACKGROUND: Oroxylum indicum (L.) Kurz (Bignoniaceae) has been widely used for the treatment of respiratory infections and gastrointestinal disorders. Our previous study showed that an ethanol-water O. indicum seed extract (OISE), when combined with acarbose, reduced the risk of diabetes by 75% and effectively prevented the associated complications. Oroxin A, a major component of OISE, can activate PPARgamma and inhibit alpha-glucosidase and it represents a promising candidate for diabetes intervention.; PURPOSE: The aim of this study is to investigate the effect of oroxin A from O. indicum on the progression of prediabetes to diabetes and the underlying mechanisms in streptozotocin and high-fat-diet induced prediabetic mice.; METHODS: Oroxin A was purified from OISE and its PPARgamma transcriptional activation was determined in vitro and in vivo. The prediabetic mice were established by high-fat diet and streptozotocin, which was followed by treatment with oroxin A. The effect of oroxin A was determined by analysis of the lipid profiles, oxidative stress, hepatic function and histology. The mechanism of oroxin A was also investigated.; RESULTS: Oroxin A is a compound with low toxicity that has reduced the relative risk of progression from prediabetes to diabetes by 66.7% without inducing weight gain or hepatotoxicity. Oroxin A also improved the complications of prediabetes, such as lipid metabolism dysfunction and liver injury. Results of mechanism studies suggested that oroxin A is a partial PPARgamma agonist that can activate PPARgamma transcriptional activation in vitro and in vivo. Oroxin A also exhibited an inhibitory activity against alpha-glucosidase and an antioxidant capacity.; CONCLUSION: Oroxin A prevents the progression from prediabetes to diabetes through a multi-pathway intervention mechanism. Copyright © 2017 Elsevier GmbH. All rights reserved.